GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicarious Surgical Inc (NYSE:RBOT) » Definitions » Sloan Ratio %

Vicarious Surgical (Vicarious Surgical) Sloan Ratio % : -0.81% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vicarious Surgical Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Vicarious Surgical's Sloan Ratio for the quarter that ended in Mar. 2024 was -0.81%.

Warning Sign:

When sloan ratio (30.88)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Mar. 2024, Vicarious Surgical has a Sloan Ratio of -0.81%, indicating the company is in the safe zone and there is no funny business with accruals.


Vicarious Surgical Sloan Ratio % Historical Data

The historical data trend for Vicarious Surgical's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicarious Surgical Sloan Ratio % Chart

Vicarious Surgical Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
-78.94 -0.34 51.12 30.88

Vicarious Surgical Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.54 37.96 39.40 30.88 -0.81

Competitive Comparison of Vicarious Surgical's Sloan Ratio %

For the Medical Devices subindustry, Vicarious Surgical's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicarious Surgical's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicarious Surgical's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Vicarious Surgical's Sloan Ratio % falls into.



Vicarious Surgical Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Vicarious Surgical's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-71.071--62.305
--45.783)/119.864
=30.88%

Vicarious Surgical's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-61.15--58.193
--2.099)/105.286
=-0.81%

Vicarious Surgical's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -15.334 (Jun. 2023 ) + -15.704 (Sep. 2023 ) + -13.111 (Dec. 2023 ) + -17.001 (Mar. 2024 ) = $-61.15 Mil.
Vicarious Surgical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was -15.082 (Jun. 2023 ) + -17.283 (Sep. 2023 ) + -11.37 (Dec. 2023 ) + -14.458 (Mar. 2024 ) = $-58.19 Mil.
Vicarious Surgical's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was -6.356 (Jun. 2023 ) + -0.644 (Sep. 2023 ) + 5.045 (Dec. 2023 ) + -0.144 (Mar. 2024 ) = $-2.10 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vicarious Surgical  (NYSE:RBOT) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, Vicarious Surgical has a Sloan Ratio of -0.81%, indicating the company is in the safe zone and there is no funny business with accruals.


Vicarious Surgical Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Vicarious Surgical's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicarious Surgical (Vicarious Surgical) Business Description

Traded in Other Exchanges
N/A
Address
78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.
Executives
William John Kelly officer: CFO and Treasurer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Adam David Sachs director, 10 percent owner, officer: President and CEO C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Sammy Khalifa director, 10 percent owner, officer: Chief Technology Officer C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
June Morris officer: CLO, General Counsel and Sec C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
John Mazzola officer: Chief Operating Officer TRANSMEDICS INC, 200 MINUTEMAN ROAD, ANDOVER MA 01810
Khosla Ventures Opportunity Associates Ii, Llc 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures V, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
Khosla Ventures Opportunity Ii, L.p. 10 percent owner 2128 SAND HILL ROAD, MENLO PARK CA 94025
David D Ho director UNIT 1008, 10/F, CHAMPION TOWER, 3 GARDEN ROAD, CENTRAL K3 00000
Philip Liang director C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Brendel Victoria Carr director C/O VICARIOUS SURGICAL, INC., 78 FOURTH AVENUE, WALTHAM MA 02451
Beverly A Huss director C/O ACCURAY INCORPORATED, 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
E15 Fund Ii, Lp other: Sole Shareholder C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Shrikant Patnaik other: Principal C/O VICARIOUS SURGICAL INC., 78 4TH AVENUE, WALTHAM MA 02451
Ric Fulop director C/O DESKTOP METAL, INC., 63 THIRD AVENUE, BURLINGTON MA 01803

Vicarious Surgical (Vicarious Surgical) Headlines